2Ikeguchi M, Liu J, Kaibara N. Expression of Survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment.Apoptosis, 2002, 7 : 23-29.
3Vignati S,Godegoni A,Polato F,et al.Trail activity in human ovarian cancer cells:potentiation of the action of cytotoxic drugs.Eur J Cancer,2002,38:177-183.
4Tomek S,Koestler W,Hornk P,et al.Trail-induced apoptosis and interaetion with cytotoxic agents in soft tissue sarcoma cell lines.Eur J Cancer,2003,39:1318-1329.
5Shin EC,Seong YR,Kim CH,et al.Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis,and the resistance is abolished by cisplatin.Exp Mol Med 2002,34:114-122.
7Lacour S,Hammann A,Wotawa A,et al.Anticancer agents sensitize tumor cells to tumor neerusis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.Cancer Rces,2001,61:1645-1651.
8Evdokiou A,Bourulexis S,Atkins GJ,et al.Chemotherapeutic agents sensitize osteogenic sarcoma cells,but not normal human bone cells,to Apo21/TRIL-induced apoptosis.Int J Cancer,2002,99:491-504.
9Isfort RJ, Cody DB, Lovell G, et al. Analysis of oncogene ,tumor repressor genes,autocrine growth-factor production,and differentiation state of human osteosarcoma cell lines. Mol Carcinog, 1995,14:170-178.
10Gamberi G, Benassi MS, Bohling T, et al. C-myc and C-fos in human osteosarcoma:Prognostic value of mRNA and protein expression. Oncology, 1998, 55:556-563.
7Plotz W, Rechl H, Burgkart R, et al. Limb salvage with tumor endoprostheses for malignant tumors of the knee. Clin Orthop, 2002,(405):207-215.
8Enneking WF, Dunham W, Gebhardt MC, et al. A system for the functional evaluatl on of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.Clin Orthop, 1993,(286):241-246.
9Kotz R, Dominkus M, Zettl T, et al. Advances in bone tumour treatment in 30 years with respect to suevival and limb salvage. A single institution experience. Int Orthop, 2002,26:197-202.
10Bacci G, Longhi A, V ersari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer, 2006,106:1154-1161.
